ArticleClinical & translational immunology2020

Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells.

Jack D Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.